Tus kws kho mob
P31-19 Medicare Crossover Process Change Effective During Second Quarter 2019
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2019
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2481 - 2490 ntawm 4179
Tus kws kho mob
P30-19 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization, Notification, and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2019
Tus kws kho mob
2019 March Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P26-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial & Medicare Advantage Lines of Business – Effective May 6, 2019
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P28-19 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Members – eviCore Healthcare Utilization Management Program
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P25-19 Medicare Advantage PPO Network Sharing Frequently Asked Questions
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P29-19 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Members – eviCore Healthcare Utilization Management Program
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P24-19 Blue Cross to Decommission Legacy Claims System
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2019
Tus kws kho mob
QP20-19 Pharmacy Benefit Exclusion for Ultomiris (ravulizumab-cwvz) IV Injection
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 13, 2019
Tus kws kho mob
QP22-19 Pharmacy Benefit Update - New Drug-Related Step Therapy Criteria: Methotrexate Injectable
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 27, 2019